ENTITY zumilokibart

zumilokibart

PulseAugur coverage of zumilokibart — every cluster mentioning zumilokibart across labs, papers, and developer communities, ranked by signal.

Total · 30d

0

0 over 90d

Releases · 30d

0

0 over 90d

Papers · 30d

0

0 over 90d

TIER MIX · 90D

No coverage in the last 90 days.

TOPICS

RECENT · PAGE 1/1 · 1 TOTAL

RESEARCH · CL_109017 · Jun 24 · 16:30

AbbVie buys Apogee for $10.9B; AI startup Cadence raises $100M

AbbVie has acquired Apogee Therapeutics for $10.9 billion to bolster its immunology franchise with Apogee's lead drug, zumilokibart, which shows promise in treating autoimmune conditions. Separately, the AI startup Cade…